Stable Coronary Artery Disease
25
2
2
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.0%
2 terminated out of 25 trials
88.2%
+1.7% vs benchmark
16%
4 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (25)
A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease
A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
Cardiovascular Events Related to Treated Coronary Arteries in Stable Multivessel CAD
Coronary Laser Atherectomy Registry From an International Taskforce
Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease
Precise Percutaneous Coronary Intervention Plan (P3) Study
Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents
Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity
Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease
Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept
Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention
To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent
Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CAD
Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions